Rosita Lupi | ADC Platform Head
Nerviano Medical Sciences Srl

Rosita Lupi, PhD, MBA is Head of the ADC Portfolio at Nerviano Medical Sciences, where she leads the development of an innovative Antibody Drug Conjugate platform in oncology. With over 20 years of experience in drug discovery and preclinical development, she has contributed to the advancement of multiple targeted therapies from early research to clinical candidate selection. Dr. Lupi holds a PhD in Biochemistry and has authored 40+ peer-reviewed publications and patents in the field of oncology drug development.